OptimizeRx Corporation (OPRX)
Helps pharmaceutical companies reach patients and doctors with targeted ads and prescription information.
$6.34-0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-49.3%
The outlook
OPRX is trading near the bottom of its 52-week range with an unusually high average analyst price target sitting around 96% above the current price. Analyst coverage is solidly bullish with a strong buy consensus, though the stock's recent price trend shows mixed momentum against its moving averages.
What’s behind the score
Analyst consensusStrong Buy — 1.2 avg of 5 analysts
Price trendMixed vs its moving averages
52-week range10% of the way from its 52-week low to high
Price targetAvg target +96% vs current price
Analyst price target
~12-month · 5 analysts$12.40average target+95.6% vs now
Now $6.34
Low $9.00High $18.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$119.0M
52-wk high
$22.25
52-wk low
$4.54
50-day avg
$5.56
200-day avg
$9.96
Trailing P/E
17.6